Agilent Technologies Inc - Company Profile
Powered by 
All the data and insights you need on Agilent Technologies Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Agilent Technologies Inc Strategy Report
- Understand Agilent Technologies Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
Agilent Technologies Inc (Agilent) is a provider of analyzing instruments, reagents, and consumables for laboratory processes. It also offers allied software and services. The company is primarily focused on scientific research, patient diagnostics, and safety testing for water, food, and pharmaceuticals. Its product portfolio includes mass spectrometry, microarray solutions, flow cytometry, vacuum technologies and others. Agilent caters to varied industries, including contract research organizations (CROs), contract manufacturing organizations (CMOs), pharmaceuticals, diagnostics, applied materials, and chemicals. The company has a significant presence across the world, with sales offices, logistics centers, R&D centers and business facilities. It commercializes its products through a network of direct sales agents, distributors, resellers, manufacturers' representatives and electronic commerce. Agilent is headquartered in Santa Clara, California, the US.
Headquarters
United States of America
Address
5301 Stevens Creek Blvd, Santa Clara, California, 95051
Website
www.agilent.com
Telephone
1 408 3458886
No of Employees
17,700
Industry
Medical Equipment
Ticker Symbol & Exchange
A (NYSE)
Revenue (2022)
$6.8B
-0.2%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-1.1%
(2022 vs 2021)
Market Cap*
$39.4B
Net Profit Margin (2022)
XYZ
-0.9%
(2022 vs 2021)
* As of and is in US$
Agilent Technologies Inc premium industry data and analytics
Products and Services
| Products | Services | Brands |
|---|---|---|
| Analytical Instruments and Supplies: | CrossLab Instrument | AccuScript |
| Chromatography | Service and Repair | AdvanceBio |
| Mass Spectrometry | Compliance | AffinityScript |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
| XYZ | XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Contracts/Agreements | In April, the company entered into a partnership with Transcenta Holding Limited to introduce a Claudin 18.2(CLDN 18.2) companion diagnostic to support TranStar301 global Phase III pivotal trial of Osemitamab (TST001) in combination with Nivolumab and chemotherapy. |
| 2024 | Contracts/Agreements | In April, the company announced a collaboration with the University of California San Diego to create the Agilent Center of Excellence in Cellular Intelligence. |
| 2024 | New Products/Services | In April, the company introduced the Advanced Dilution System, the ADS 2. |
Competitor Comparison
| Key Parameters | Agilent Technologies Inc | Thermo Fisher Scientific Inc | Abbott Laboratories | Danaher Corp | Illumina Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Santa Clara | Waltham | Abbott Park | Washington | San Diego |
| State/Province | California | Massachusetts | Illinois | WashingtonD.C. | California |
| No. of Employees | 17,700 | 122,000 | 114,000 | 61,000 | 10,590 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Mike McMullen | President; Director; Chief Executive Officer | Executive Board | 2015 | 61 |
| Robert W. McMahon | Chief Financial Officer; Senior Vice President; President - Diagnostics and Genomics Group - Interim | Senior Management | 2018 | 54 |
| Katharine Knobil | Chief Medical Officer | Senior Management | 2021 | - |
| Rodney Gonsalves | Vice President; Principal Accounting Officer; Corporate Controller | Senior Management | - | 57 |
| Padraig McDonnell | Chief Commercial Officer; Senior Vice President; President - Agilent CrossLab Group | Senior Management | 2021 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward